MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 07 report with the FDA on 2012-01-10 for ENPATH 4046 manufactured by External Manufacturer.
[2414327]
Boston scientific received information that this product was part of a system revision due to infection. There were no additional adverse effects reported.
Patient Sequence No: 1, Text Type: D, B5
[9683439]
As no further information concerning this report is expected, (b)(4) investigation is complete. This investigation will be updated should further information be provided.
Patient Sequence No: 1, Text Type: N, H10
Report Number | 2124215-2011-19468 |
MDR Report Key | 2406250 |
Report Source | 07 |
Date Received | 2012-01-10 |
Date of Report | 2011-11-03 |
Date of Event | 2011-11-03 |
Date Mfgr Received | 2011-11-03 |
Date Added to Maude | 2012-01-10 |
Event Key | 0 |
Report Source Code | Manufacturer report |
Manufacturer Link | Y |
Number of Patients in Event | 0 |
Adverse Event Flag | 3 |
Product Problem Flag | 3 |
Reprocessed and Reused Flag | 3 |
Reporter Occupation | MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE |
Health Professional | 3 |
Initial Report to FDA | 3 |
Report to FDA | 3 |
Event Location | 0 |
Manufacturer Contact | SHARON ZURN |
Manufacturer Street | 4100 HAMLINE AVE. N |
Manufacturer City | ST. PAUL MN 55112 |
Manufacturer Postal | 55112 |
Manufacturer Phone | 6515824786 |
Manufacturer G1 | EXTERNAL MANUFACTURER |
Single Use | 3 |
Previous Use Code | 3 |
Event Type | 3 |
Type of Report | 3 |
Brand Name | ENPATH |
Generic Name | IMPLANTABLE LEAD |
Product Code | NHW |
Date Received | 2012-01-10 |
Model Number | 4046 |
ID Number | ENPATH |
Device Expiration Date | 2012-11-01 |
Operator | LAY USER/PATIENT |
Device Availability | N |
Device Eval'ed by Mfgr | R |
Device Sequence No | 1 |
Device Event Key | 0 |
Manufacturer | EXTERNAL MANUFACTURER |
Patient Number | Treatment | Outcome | Date |
---|---|---|---|
1 | 0 | 1. Hospitalization; 2. Life Threatening; 3. Required No Informationntervention | 2012-01-10 |